Mednax Inc Stock Today

MD Stock  USD 12.13  0.23  1.93%   

Performance

21 of 100

 
Weak
 
Strong
Solid

Odds Of Distress

Less than 21

 
High
 
Low
Low
Mednax is trading at 12.13 as of the 5th of October 2024, a 1.93 percent increase since the beginning of the trading day. The stock's lowest day price was 11.98. Mednax has about a 21 % chance of experiencing some form of financial distress in the next two years of operation and had a somewhat solid performance during the last 90 days. Note, on October 29, 2018, Representative Greg Gianforte of US Congress acquired $50k to $100k worth of Mednax Inc's common stock.
Business Domain
Health Care Equipment & Services
IPO Date
19th of September 1995
Category
Healthcare
Classification
Health Care
Pediatrix Medical Group, Inc., together with its subsidiaries, provides newborn, maternal-fetal, pediatric cardiology, and other pediatric subspecialty care services in the United States and Puerto Rico. Pediatrix Medical Group, Inc. was founded in 1979 and is based in Sunrise, Florida. The company has 85.87 M outstanding shares of which 4.79 M shares are now sold short in the market by investors with about 8.65 days to cover all shorted shares. More on Mednax Inc

Moving together with Mednax Stock

  0.64CI Cigna CorpPairCorr
  0.69LH LaboratoryPairCorr

Moving against Mednax Stock

  0.94OM Outset Medical Earnings Call This WeekPairCorr
  0.89ELAB Elevai Labs, CommonPairCorr
  0.88EDAP EDAP TMS SAPairCorr
  0.83VREX Varex Imaging Corp Fiscal Year End 12th of November 2024 PairCorr
  0.82VTAK Catheter PrecisionPairCorr
  0.8DXCM DexCom IncPairCorr

Mednax Stock Highlights

ESG Sustainability
Environmental
Governance
Social
CEO DirectorJames MD
Thematic IdeaHealthcare (View all Themes)
Business ConcentrationHealth Care Providers & Services, Health Care Equipment & Services, Health Care, NYSE Composite, SP Small-Cap 600, Healthcare, Health Care, Health Care Providers & Services, Medical Care Facilities, Healthcare (View all Sectors)
Average Analyst Recommendation
Financial Strength
Current ValueLast YearChange From Last Year 10 Year Trend
Asset Turnover0.790.8986
Fairly Down
Pretty Stable
Gross Profit Margin0.20.2113
Notably Down
Slightly volatile
Total Current Liabilities284.3 M388.9 M
Way Down
Slightly volatile
Non Current Liabilities Total731 M981.8 M
Way Down
Slightly volatile
Total Assets2.2 B2.2 B
Slightly Up
Very volatile
Total Current Assets382.4 M483.5 M
Significantly Down
Slightly volatile
Total Cash From Operating Activities210.1 M137.3 M
Way Up
Pretty Stable
Debt Levels
Mednax can leverage the use of borrowed funds to amplify returns from an investment. In general, analyzing the relationship between debt to total assets helps investors to understand Mednax's financial leverage. It provides some insight into what part of Mednax's total assets is financed by creditors.
Liquidity
Mednax Inc reports 701.65 M of total liabilities with total debt to equity ratio (D/E) of 1.03, which is normal for its line of buisiness. Mednax Inc has a current ratio of 1.36, which is generally considered normal. Note however, debt could still be an excellent tool for Mednax to invest in growth at high rates of return.

Change In Cash

66.61 Million
Mednax Inc (MD) is traded on New York Stock Exchange in USA. It is located in 1301 Concord Terrace, Sunrise, FL, United States, 33323 and employs 5,450 people. Mednax is listed under Health Care Providers & Services category by Fama And French industry classification. The company currently falls under 'Mid-Cap' category with a market capitalization of 1.04 B. Mednax Inc is active under Health Care Providers & Services sector as part of Health Care industry. The entity has 85.87 M outstanding shares of which 4.79 M shares are now sold short in the market by investors with about 8.65 days to cover all shorted shares. Mednax Inc reports about 9.82 M in cash with 137.32 M of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 1.29.
Check Mednax Probability Of Bankruptcy
Ownership Allocation
The majority of Mednax outstanding shares are owned by institutional investors. These third-party entities are usually referred to as non-private investors looking to shop for positions in Mednax Inc to benefit from reduced commissions. Consequently, institutional holders are subject to a different set of regulations than regular investors in Mednax Inc. Please pay attention to any change in the institutional holdings of Mednax as this could imply that something significant has changed or is about to change at the company. Please note that on October 29, 2018, Representative Greg Gianforte of US Congress acquired $50k to $100k worth of Mednax Inc's common stock.
Check Mednax Ownership Details

Mednax Stock Institutional Holders

InstituionRecorded OnShares
Amvescap Plc.2024-06-30
1.4 M
Segall Bryant & Hamill2024-06-30
1.3 M
Dana Investment Advisors Inc2024-06-30
M
Jpmorgan Chase & Co2024-06-30
M
Citadel Advisors Llc2024-06-30
994.5 K
Aqr Capital Management Llc2024-06-30
942.4 K
Invenomic Capital Management, Lp2024-06-30
932.1 K
Bank Of America Corp2024-06-30
899.9 K
Northern Trust Corp2024-06-30
783.6 K
Blackrock Inc2024-06-30
13.7 M
Vanguard Group Inc2024-06-30
10.6 M
View Mednax Diagnostics

Mednax Historical Income Statement

At present, Mednax's EBIT is projected to decrease significantly based on the last few years of reporting. The current year's EBITDA is expected to grow to about 288.6 M, whereas Interest Expense is forecasted to decline to about 24.4 M. View More Fundamentals

Mednax Stock Against Markets

Mednax Corporate Directors

Enrique SosaIndependent DirectorProfile
Paul GabosIndependent DirectorProfile
Pascal GoldschmidtIndependent DirectorProfile
Waldemar CarloIndependent DirectorProfile

Additional Information and Resources on Investing in Mednax Stock

When determining whether Mednax Inc is a strong investment it is important to analyze Mednax's competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact Mednax's future performance. For an informed investment choice regarding Mednax Stock, refer to the following important reports:
Check out Correlation Analysis to better understand how to build diversified portfolios, which includes a position in Mednax Inc. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in unemployment.
You can also try the Portfolio Analyzer module to portfolio analysis module that provides access to portfolio diagnostics and optimization engine.
Is Health Care Providers & Services space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Mednax. If investors know Mednax will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Mednax listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth
(0.71)
Earnings Share
(2.31)
Revenue Per Share
24.207
Quarterly Revenue Growth
0.007
Return On Assets
0.0443
The market value of Mednax Inc is measured differently than its book value, which is the value of Mednax that is recorded on the company's balance sheet. Investors also form their own opinion of Mednax's value that differs from its market value or its book value, called intrinsic value, which is Mednax's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Mednax's market value can be influenced by many factors that don't directly affect Mednax's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Mednax's value and its price as these two are different measures arrived at by different means. Investors typically determine if Mednax is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Mednax's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.